Edition: United Kingdom  
One News Page
“Probably the fastest-access news portal in the world”
> >

FDA approves AstraZeneca's asthma drug

Reuters Wednesday, 15 November 2017 ()
(Reuters) - Anglo-Swedish pharmaceutical firm AstraZeneca Plc on Tuesday said the U.S. Food and Drug Administration approved its drug benralizumab, as an add-on treatment for patients with severe asthma aged 12 years and older.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

AstraZeneca ticks another box as U.S. approves severe asthma drug

LONDON (Reuters) - AstraZeneca has achieved another milestone in rebuilding its drug portfolio with U.S. approval of a drug for severe asthma as the company...
Reuters - Health


You Might Like


Other recent news in Health

EUROPE's drug industry waits for white smoke in BrusselsFLORIDA confirms second local Zika virus infection for 2017
JESSE JACKSON reveals he has Parkinson's diseaseInjured defector's parasites and diet hint at hard life in NORTH KOREA
Steep alcohol taxes drive TURKEY's drinkers to home-brewClues In That Mysterious Radioactive Cloud Point Toward RUSSIA
Good Samaritan Hospital celebrates WORLD PREMATURITY DAYHUMAN HEAD TRANSPLANT Surgeon Says Trial Run Is a Success

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+